The European Molecular Biology Laboratory (EMBL) is an international scientific research organisation with sites in Heidelberg, Cambridge, Barcelona, Grenoble, Hamburg and Rome. The research group of Wolfgang Huber (www.huber.embl.org) develops computational and statistical methods for emerging experimental techniques aimed at biological discovery and biomedical and biotechnological translation.
The Faculty of Medicine of the University of Heidelberg is a leading biomedical research institution in Europe; its hospital is one of the largest medical centres in Germany. The research group of Sascha Dietrich aims to bring biology-based individualized treatment of lymphoma and leukemia into clinical practice; they use a systems medicine approach that integrates functional assays, multi-omic profiling, bioinformatic analysis, mathematical modeling and clinical exploitation.
The two groups form a joint team within the Molecular Medicine Partnership Unit (MMPU) between EMBL and Heidelberg University Hospital. They also collaborate with the German Cancer Research Centre (DKFZ), one of the largest cancer research centres in the world, on single cell omics technologies. Huber is a unit member of the Heidelberg node of the European Lab for Learning and Intelligent Systems (ELLIS).
Altogether, the open positions are placed in a highly motivated, collegial and international scientific environment with unique combined expertise in cell and molecular biology, bioinformatics, mathematical modelling and clinical care, and they provide the opportunity to train in an exciting and promising interdisciplinary area of research